Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women
Roy M. Gulick(New York University), Kenneth H. Mayer(Miriam Hospital), Marc Siegel(George Washington University), Timothy Wilkin(Cornell University), Robert A. Salata(Case Western Reserve University), Yukari C. Manabe(Johns Hopkins University), Shobha Swaminathan(Rutgers, The State University of New Jersey), Sally Hodder(West Virginia University), Raphael J. Landovitz(APLA Health), Adriana Andrade(Johns Hopkins University), Marybeth McCauley(Family Health International 360), James F. Rooney(Gilead Sciences (United States)), Craig W. Hendrix(Unknown), Karin L. Klingman(National Institutes of Health), Ian Frank(Norwegian Womens Public Health Association), Wairimu Chege(National Institutes of Health), Ken Ho(University of Pittsburgh), Susan H. Eshleman(Johns Hopkins University), Mark A. Marzinke(Family Health International 360), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Cheryl Marcus(University of North Carolina at Chapel Hill), Joanne D. Stekler(University of Washington), P. Andrew(Family Health International 360), K. Rivet Amico(University of Cape Town), Alex R. Rinehart, Jorge Santana(University of Puerto Rico System), Paul Richardson(Johns Hopkins University), Leslie Cottle(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alicia Young(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ian McGowan(University of Pittsburgh)
Cited by 31
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k